Patents by Inventor Shuen-Hsiang CHOU

Shuen-Hsiang CHOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intralymphatic delivery of hyaluronan nanoparticle for cancer metastasis
    Patent number: 10632081
    Abstract: Disclosed is an intralymphatic delivery method for treating lymphatic cancer using hyaluronan nanoparticles. These nanoparticles include a hyaluronic acid derivative and a platinum compound. The hyaluronan derivative includes hyaluronic acid, modified histidine and optionally one or more of a polymer or a C4-C20 alkyl. The hyaluronic acid derivative may include linking group(s) that connect the polymer or the C4-C20 alkyl to the hyaluronic acid. The platinum compound includes dichloro(1,2-diaminocyclohexane) platinum (DACHPt), cisplatin and oxaliplatin. This intralymphatic delivery method offers significant advantages for the use of platinum medicines in treating lymphatic cancer.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: April 28, 2020
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Chih-Peng Liu, Ya-Chin Lo, Ming-Cheng Wei, Maggie Lu, Shuen-Hsiang Chou, Shih-Ta Chen, Hsiang-Wen Tseng
  • Recipe for in-situ gel, and implant, drug delivery system formed thereby
    Patent number: 9757330
    Abstract: The disclosure provides a recipe for in-situ gel, formed by dissolving at least one polymer and at least one gel prevention agent in a polar solvent to form a solution and placing the solution in a condition for in-situ forming gels. The disclosure also provides an implant and a drug delivery system formed by the recipe.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: September 12, 2017
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Felice Cheng, Maggie J. M. Lu, Yi-Ju Ko, Min-Ying Lin, Shuen-Hsiang Chou
  • INTRALYMPHATIC DELIVERY OF HYALURONAN NANOPARTICLE FOR CANCER METASTASIS
    Publication number: 20160361268
    Abstract: Disclosed is an intralymphatic delivery method for treating lymphatic cancer using hyaluronan nanoparticles. These nanoparticles include a hyaluronic acid derivative and a platinum compound. The hyaluronan derivative includes hyaluronic acid, modified histidine and optionally one or more of a polymer or a C4-C20 alkyl. The hyaluronic acid derivative may include linking group(s) that connect the polymer or the C4-C20 alkyl to the hyaluronic acid. The platinum compound includes dichloro(1,2-diaminocyclohexane) platinum (DACHPt), cisplatin and oxaliplatin. This intralymphatic delivery method offers significant advantages for the use of platinum medicines in treating lymphatic cancer.
    Type: Application
    Filed: April 29, 2016
    Publication date: December 15, 2016
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Chih-Peng LIU, Ya-Chin LO, Ming-Cheng WEI, Maggie LU, Shuen-Hsiang CHOU, Shih-Ta CHEN, Hsiang-Wen TSENG
  • Pharmaceutical composition
    Patent number: 9408917
    Abstract: The disclosure provides a pharmaceutical composition. The pharmaceutical composition includes a chitosan with palmitoyl groups and an active agent. According to another embodiment, the pharmaceutical composition can further include a gelling accelerating agent. According to an embodiment of the disclosure, the active agent of the disclosure can be administered in the form of a nano-drug, liposome, micelle, or microparticle.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: August 9, 2016
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Maggie J. M. Lu, Yu-Wen Lo, Chih-Peng Liu, Chia-Wen Huang, Shuen-Hsiang Chou, Po-Hung Lai, Tsan-Lin Hu, Min-Ying Lin, Chia-Mu Tu
  • RECIPE FOR IN-SITU GEL, AND IMPLANT, DRUG DELIVERY SYSTEM FORMED THEREBY
    Publication number: 20150111834
    Abstract: The disclosure provides a recipe for in-situ gel, formed by dissolving at least one polymer and at least one gel prevention agent in a polar solvent to form a solution and placing the solution in a condition for in-situ forming gels. The disclosure also provides an implant and a drug delivery system formed by the recipe.
    Type: Application
    Filed: September 17, 2014
    Publication date: April 23, 2015
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Felice CHENG, Maggie J.M. LU, Yi-Ju KO, Min-Ying LIN, Shuen-Hsiang CHOU
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20140199369
    Abstract: The disclosure provides a pharmaceutical composition. The pharmaceutical composition includes a chitosan with palmitoyl groups and an active agent. According to another embodiment, the pharmaceutical composition can further include a gelling accelerating agent. According to an embodiment of the disclosure, the active agent of the disclosure can be administered in the form of a nano-drug, liposome, micelle, or microparticle.
    Type: Application
    Filed: June 25, 2013
    Publication date: July 17, 2014
    Inventors: Maggie J.M. LU, Yu-Wen LO, Chih-Peng LIU, Chia-Wen HUANG, Po-Hung LAI, Tsan-Lin HU, Min-Ying LIN, Shuen-Hsiang CHOU, Chia-Mu TU